UPClytics
View all cases

UPC CFI 2562/2026

Jul 16, 2026·EP4241767 Unitary patent · NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS

Case details
Status
Written Phase
Action
Infringement
Category
Main infringement action
Parties
Claimants
Representatives
  • Mark van Gardingen
Respondents
Representatives
Division
The Hague LD
Technology
  • Chemistry
    Pharmaceuticals
Language
English
EPO Opposition
  • ModernaTX, Inc.Withdrawn2025-04-29
  • Merck Sharp & Dohme (UK) LimitedWithdrawn2025-07-23
  • Arrowhouse GmbHAdmissible2025-07-23
  • Keltie LLPAdmissible2025-07-23
How this compares
The court's record for this kind of case, counted in first-instance rulings. A figure in brackets is the number of rulings a rate rests on.
Infringement foundMedian days to first decision
All UPC53% (62/117)124
The Hague LDLockedLocked
Judge Edger BrinkmanLockedLocked
Judge Margot KokkeLockedLocked
Judge Samuel GranataLockedLocked

At the UPC: Genevant Sciences GmbH (9 cases)·Pfizer Group (31 cases)

This dispute contains 1 other proceedings

UPC CFI 2566/2026

2 other defendants litigating the same or a related patent

UPC CFI 607/2025·UPC CFI 192/2025

Start a free trial to see how each one ended.

More cases: The Hague LD·2026

Document titleDatePublic
Communication2026-09-21Not public
Receipt2026-09-21Not public
Cover sheet2026-09-21Not public
Document2026-09-21Not public
Communication2026-09-18Not public
Receipt2026-09-18Not public
Cover sheet2026-09-18Not public
Further pleadings2026-09-18Not public
Receipt2026-09-15Not public
Cover sheet2026-09-15Not public